The global testicular cancer treatment market is experiencing significant expansion. Driven by factors such as increasing incidence rates and advancements in treatment, the market is poised for substantial revenue generation over the forecast period. A key driver shaping the market is the need for minimally invasive procedural techniques, coupled w